$26.27
arrow_drop_down6.37%Key Stats | |
---|---|
Open | $28.05 |
Prev. Close | $28.06 |
EPS | -2.02 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 26.02 | 28.39 |
52 Week Range | 24.35 | 73.80 |
Ratios | |
---|---|
EPS | -2.02 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Why Apellis Pharmaceuticals Stock Was Tumbling on Tuesday
1 Nasdaq Stock Down 62% This Year That Could Double Your Money, According to a Wall Street Analyst
2023 Vision Health Report: Post Pandemic Recovery-Challenges Remain
Investigation Alert: MacroGenics, Apellis Pharmaceuticals, Teradata and Maplebear - Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information
Geographic Atrophy (GA) Market Size to Hit USD 50.0 Billion by 2032 with a 8.6% CAGR – SNS Insider
Apellis (APLS) Falls on Second Negative CHMP Opinion for GA Drug